Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Net Debt / EBITDA

Adverum Biotechnlgs Net Debt / EBITDA Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Net Debt / EBITDA from 2013 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Adverum Biotechnlgs Net Debt / EBITDA for the quarter ending June 06, 2020 was $2m a 3.19% increase of 0m year over year
  • Adverum Biotechnlgs Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $3m a 15.42% increase of 0m year over year
  • Adverum Biotechnlgs Annual Net Debt / EBITDA for 2019 was $2m a -29.96% decrease of -1m from 2018
  • Adverum Biotechnlgs Annual Net Debt / EBITDA for 2018 was $3m a -18.73% decrease of -1m from 2017
  • Adverum Biotechnlgs Annual Net Debt / EBITDA for 2017 was $3m a -36.98% decrease of -1m from 2016
Other Ratios Metrics:
  • Adverum Biotechnlgs Total Debt / Capital for the quarter ending December 12, 2017 was $0m a 56.92% increase of 0m year over year
  • Adverum Biotechnlgs Other Liabilities for the quarter ending December 12, 2018 was $2m a -14.42% decrease of 0m year over year
  • Adverum Biotechnlgs Total Debt / Equity for the quarter ending December 12, 2017 was $0m a 56.98% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Net Debt / EBITDA Data

06/2020$2m
03/2020$3m
12/2019$2m
09/2019$2m
06/2019$3m
03/2019$3m
12/2018$3m
09/2018$3m
06/2018$3m
03/2018$4m

Annual ADVM Net Debt / EBITDA Data

2019$2m
2018$3m
2017$3m
2016$5m
2015$6m
2014$7m
2013$0m
2012$0m